Clinical Trials Browser

Phase 1 × Completed × soluble LAG-3 protein, human × Clear all

NCT02676869 2019-12-18

TACTI-mel

Phase 1 Completed

Melanoma

NCT00349934 2010-01-07

IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma

Phase 1 Completed

Breast Neoplasms

NCT00351949 2010-01-07

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Phase 1 Completed

Carcinoma, Renal Cell